Abengoa Yield Assigned BB+ Rating by Standard & Poor's

20:00 EDT 2 Jun 2015 | Globe Newswire

WASHINGTON, June 3, 2015 (GLOBE NEWSWIRE) -- Abengoa Yield (Nasdaq:ABY), the sustainable total return company that owns a diversified portfolio of contracted assets in the energy and environment sectors, announced today that it has been assigned a corporate credit rating of BB+ with a stable outlook by Standard & Poor's Rating Services. Additionally, Abengoa Yield senior unsecured notes due in 2019 were also assigned the same BB+ credit rating and the senior secured credit facility due in 2018 was assigned a BBB rating.

Standard & Poor's highlighted in its press release the credit strength of a portfolio of renewable and conventional generation and electric transmission assets that generate stable cash flow from long-term revenue contracted assets with highly rated counterparties.

Javier Garoz, CEO of Abengoa Yield said, "This rating represents an important milestone for us. It will enhance our ability to finance acquisitions in a cost efficient manner, which will allow us to continue creating value to our shareholders delivering accretive growth."

About Abengoa Yield

Abengoa Yield is a total return company that owns a diversified portfolio of contracted renewable energy, power generation, electric transmission and water assets in North America, South America and certain markets in EMEA. We focus on providing a predictable and growing quarterly dividend to our shareholders (

         Eduard Soler

         Communication Department
         Patricia Malo de Molina
         Tel: +34 954 93 71 11

         Investor Relations
         Leire Perez
         Tel: +44 20 7098 4384

More From BioPortfolio on "Abengoa Yield Assigned BB+ Rating by Standard & Poor's"

Quick Search


Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.